Twenty years after cystic fibrosis gene identification: Where are we and what are we up to?

Pathologie Biologie

Volumn 59, Issue 3, 2011, Pages 131-133

  Edelman, A ^a   Fritsch, J ^a   Ollero, M ^a  

^a INSERM   (France)

Author keywords

CFTR; Chloride channel; Cystic fibrosis; Gene; Multifunctional protein; Phenotype

Indexed keywords

ARGININE; ATALUREN; CHAPERONE; CHLORIDE CHANNEL; CYCLIC AMP; CYCLOOXYGENASE 1; CYTOSKELETON PROTEIN; CYTOSOLIC PHOSPHOLIPASE A2; GENTAMICIN; GLUTAMIC ACID; GLYCINE; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; ISOLEUCINE; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 5; MIGLUSTAT; PDZ PROTEIN; PHENYLALANINE; PROSTAGLANDIN E2; PROTEIN S 100; RANTES; REGULATOR PROTEIN; SYNTAXIN 1; THREONINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AMINO ACID SUBSTITUTION; ANION EXCHANGE; ANTIINFLAMMATORY ACTIVITY; CFTR GENE; CHANNEL GATING; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG TARGETING; EDITORIAL; FRAMESHIFT MUTATION; GAUCHER DISEASE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; LUNG DISEASE; MISSENSE MUTATION; NONSENSE MUTATION; OXIDATION REDUCTION STATE; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EUROPE; FORECASTING; GENE FREQUENCY; HUMANS; MUTATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION MAPPING; REGISTRIES; SEQUENCE DELETION; THERAPIES, INVESTIGATIONAL;

EID: 79958759978     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.05.005     Document Type: Editorial

References (6)

1. Quinton P.M. Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 1999, 79(Suppl. 1):S3-S22.
2. Ollero M., Brouillard F., Edelman A. Cystic fibrosis enters the proteomics scene: new answers to old questions. Proteomics 2006, 6(14):4084-4099.
3. Vankeerberghen A., Cuppens H., Cassiman J.J. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst Fibros 2002, 1(1):13-29.
4. Riordan J.R. CFTR function and prospects for therapy. Annu Rev Biochem 2008, 77:701-726.
5. Amaral M.D. Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis?. Pediatr Pulmonol 2005, 39(6):479-491.
6. Verkman A.S., Galietta L.J. Chloride channels as drug targets. Nat Rev Drug Discov 2009, 8(2):153-171.